Kallyope

Kallyope

NY - New York
Biotechnology

Focus: Gut-brain axis focus

Kallyope is a life sciences company focused on Gut-brain axis focus.

Neurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

K-757 and K-833 QD
Obesity
Phase 1
Clinical Trials (1)
NCT06305351A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
Phase 1
K-757
Obesity
Phase 1
Clinical Trials (1)
NCT05900531A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers
Phase 1
K-757 and K-833
Obesity
Phase 1
Clinical Trials (1)
NCT05890950A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes
Phase 1
Elismetrep
Acute Migraine
Phase 2
Clinical Trials (1)
NCT06848075A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine
Phase 2
Phase 2
Clinical Trials (1)
NCT07116499A Study of K-645 in the Treatment of Multiple Migraine Attacks
Phase 2
K-757 120 mg BID and K-833 100 mg BID
Obesity
Phase 2
Clinical Trials (1)
NCT06019559A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 6 clinical trials